The Latest Breaking News from FDA

The Food and Drug Administration on Tuesday finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.

The move replaces a long-standing requirement that they pick up the medicine in person – although its impact has been blunted by numerous state laws limiting abortion broadly and the pills specifically

ATLANTA -- Ira Katz bustles at his pharmacy in Atlanta's Little Five Points neighborhood this cough season, serving patients who need medicine for respiratory viruses like COVID-19. He dispenses occasional packages of Paxlovid, a drug designed to nip COVID in the bud. But there aren’t as many of those Paxlovid…

U.S. health officials’ approval process for Biogen Inc.’s controversial Alzheimer’s drug was “rife with irregularities,” raising serious concerns about protocol lapses at the agency, congressional investigators said.

House report questions FDA’s approval of Alzheimer’s drug

The Food and Drug Administration's contentious approval of a questionable Alzheimer's drug is taking another hit

WASHINGTON — A joint investigation released Thursday by House Democrats identified unusual collaboration between Food and Drug Administration officials and drugmaker Biogen, highlighting potential problems in the agency’s approval of the controversial Alzheimer’s drug Aduhelm.

The Evie smart ring targets women's health and is aiming to be FDA-approved. Movano says it will ideally cost less than $300 when it launches sometime in 2023.

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…